Events | 29 January 2019 MSF statements at WHO Executive Board 144th session UN Photo/Christopher Black UN Photo/Christopher Black MSF representatives are attending the 144th session of the WHO executive board meetings and will be speaking on a number of topics. Our statements Statement | 31 January 2019 Drug-resistant infections 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min Read, watch, share Filter by - Any -EventsIssue briefLetterPress releaseSpeechStatement Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Load More
Statement | 31 January 2019 Drug-resistant infections 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min
Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min
Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min
Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
